Michael R. Hayden, Director at AbCellera Biologics, holds 1.49M shares in AbCellera Biologics (Ticker: ABCL), holds 78.30K shares in Ionis Pharmaceuticals (Ticker: IONS), holds 0.00 shares in 89bio (Ticker: ETNB). Most recently, Michael R. Hayden Bought ― shares of AbCellera Biologics on Aug 24, 2026 for an estimated value of $570.44K.
What is the percentage of profitable transactions made by Michael R. Hayden?
The percentage of profitable transactions made by Michael R. Hayden is 53%.
What is the average return per transaction made by Michael R. Hayden?
The average return per transaction made by Michael R. Hayden is 23.90%.
What stocks does Michael R. Hayden hold?
Michael R. Hayden holds: ABCL, XENE, IONS, ETNB stocks.
What was Michael R. Hayden’s latest transaction?
Michael R. Hayden latest transaction was an Informative Buy of $570.44K.
What was Michael R. Hayden's most profitable transaction?
Michael R. Hayden’s most profitable transaction was an Informative Buy of XENE stock on August 14, 2017. The return on the trade was 356.00%.
What is Michael R. Hayden's role in AbCellera Biologics?
Michael R. Hayden's role in AbCellera Biologics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.